HASSEN BORHOT: Open Payments
NPI 1457660029 · MANCHESTER, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$62,540 in 333 payments from 25 companies in 2025. Trend: 2023 $3,549 · 2024 $4,282 · 2025 $62,540
Speaker / faculty: $42,915Travel & lodging: $11,124Food & beverage: $6,094Consulting: $2,400Education: $7
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 52 | $28,739 |
| Lilly USA, LLC | 81 | $22,882 |
| ABBVIE INC. | 70 | $8,222 |
| AstraZeneca Pharmaceuticals LP | 15 | $415 |
| Exact Sciences Corporation | 10 | $264 |
| PFIZER INC. | 15 | $255 |
| GlaxoSmithKline, LLC. | 14 | $238 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 15 | $235 |
| Currax Pharmaceuticals LLC | 18 | $226 |
| Janssen Pharmaceuticals, Inc | 6 | $195 |
Products named: Wegovy, ZEPBOUND, VRAYLAR, UBRELVY, JARDIANCE, CONTRAVE, NURTEC ODT, FARXIGA.
Industry payments across CT — which companies pay providers there.
